• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

CVS Health

FDA issues warning about over-the-counter eye drops

October 30, 2023 By Sean Whooley

FDA-logo-new

The FDA issued a notice warning consumers about 26 over-the-counter eye drop products that could result in eye infections. In its notice, the FDA instructed consumers not to purchase and to immediately stop using these products. Using those eye drops could lead to the risk of infections that could result in partial vision loss or […]

Filed Under: Drug-Device Combinations, Food & Drug Administration (FDA), Optical/Ophthalmic, Recalls, Regulatory/Compliance Tagged With: Cardinal Health, CVS Health, FDA

CVS Health launches drug-pricing tool for pharmacies

April 12, 2018 By Sarah Faulkner

CVS Health

CVS Health (NYSE:CVS) announced this week that it plans to launch a program to help consumers compare drug prices at the pharmacy counter. The company’s Rx Savings Finder program is designed to enable pharmacists to evaluate individual prescriptions and find the lowest cost option for consumers. The tool is available at all CVS Pharmacy locations, the […]

Filed Under: Featured, Pharmaceuticals, Wall Street Beat Tagged With: CVS Health

CVS offers discount to uninsured for overdose reversal drug

April 6, 2018 By Sarah Faulkner

CVS Health

CVS Health (NYSE:CVS) announced yesterday that it plans to offer a discount for Narcan, the nasal spray designed to reverse the effects of opioid overdoses, to customers who do not have insurance. The company said it will cut the cost of Narcan from its list price of $125 to $94.99 – the lowest price available for […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: CVS Health, Kaleo Inc

CVS Health to buy Aetna in $69B merger

December 4, 2017 By Sarah Faulkner

CVS Health, Aetna

CVS Health (NYSE:CVS) plans to buy health insurer Aetna (NYSE:AET) in a $69 billion merger, according to a report from The New York Times. The deal comes as companies like Amazon (NSDQ:AMZN), which is reportedly trying to launch into the pharmacy business, are looking to change the way that consumers interact with the healthcare industry. The […]

Filed Under: Featured, Mergers & Acquisitions, Pharmaceuticals, Wall Street Beat Tagged With: Aetna, amazon, CVS Health

Express Scripts, CVS sued over Mylan’s EpiPen

June 6, 2017 By Sarah Faulkner

gavel

Express Scripts (NSDQ:ESRX) and CVS Health (NYSE:CVS) were among the pharmacy benefit managers named in a lawsuit last week, when a potential class of patients accused them of violating the Employee Retirement Income Security Act by failing to negotiate lower prices for Mylan’s EpiPen allergy auto-injector. The suit, filed in the Minnesota District Court, alleges that […]

Filed Under: Legal News, Pharmaceuticals, Wall Street Beat Tagged With: CVS Health, Express Scripts, Mylan

EpiPen purchasers level class action against Mylan over price hikes

April 4, 2017 By Sarah Faulkner

Mylan

Mylan (NSDQ:MYL) was hit with another class action lawsuit over the price of its EpiPen device yesterday. The lawsuit, which was filed in the Washington Western District Court, alleges that Mylan engaged in a scheme with pharmacy benefit managers to dominate the market and overcharge customers. Although the Canonsburg, Penn.-based company has been hit with several lawsuits […]

Filed Under: Auto-injectors, Drug-Device Combinations, Featured, Legal News, Pharmaceuticals, Wall Street Beat Tagged With: Centers for Medicare and Medicaid Services (CMS), CVS Health, Express Scripts, Mylan, OptumRx, U.S. Justice Dept.

Under pricing pressure, insulin maker joins CVS Reduced Rx savings program

March 17, 2017 By Sarah Faulkner

Novo Nordisk

Facing pressure from lawmakers about the prices of their drugs, some pharmaceutical companies are looking for ways to make their products more affordable and more accessible. Novo Nordisk (NYSE:NVO) said yesterday that it is teaming up with CVS Health‘s (NYSE:CVS) new prescription savings program, Reduced Rx, to offer discounts on its insulin. The company’s insulin will be […]

Filed Under: Diabetes, Featured, Pharmaceuticals, Policy, Wall Street Beat Tagged With: CVS Health, Novo Nordisk

CVS to sell cheaper, generic version of Impax’s allergy injection

January 12, 2017 By Sarah Faulkner

Impax Laboratories

CVS Health Corp. (NYSE:CVS) said today that it will start selling a generic version of Impax Laboratories‘ (NSDQ:IPXL) emergency allergy injection, Adrenaclick. The device is similar to Mylan‘s (NSDQ:MYL) EpiPen, although regulators do not consider the 2 devices to be exactly the same. The Adrenaclick has a list price of more than $400, but the generic […]

Filed Under: Drug-Device Combinations, Featured, Respiratory, Wall Street Beat Tagged With: CVS Health, Impax Laboratories, Mylan

Eli Lilly, Express Scripts offer insulin discount program

December 14, 2016 By Sarah Faulkner

Eli Lilly

Eli Lilly (NYSE:LLY) said it is teaming up with pharmacy benefit manager Express Scripts (NSDQ:ESRX) to offer discounts on the US pharma giant’s insulin products for uninsured patients and people with high-deductible insurance plans. The program will begin January 1, 2017 and will cover Lilly’s insulins Humalog, Humulin, and the biologic Basaglar. Lilly said it anticipates the program […]

Filed Under: Diabetes, Featured, Wall Street Beat Tagged With: CVS Health, Eli Lilly & Co., Express Scripts, Novo Nordisk, Sanofi-Aventis

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS